Copolymer (PGC), our patented and proprietary drug delivery technology licensed from Massachusetts General Hospital. We are focused on half-life extension and targeted delivery... is dedicated to enabling and improving injectable drugs. PharmaIN has been awarded over $6MM in peer-reviewed NIH SBIR grants to develop its Protected Graft Copolymer drug delivery... and Enabling injectable therapeutics developed internally for out-licensing Our proprietary drug delivery technology for both therapeutic and imaging agents has been proven to: Increase...

therapeutic molecules with our drug delivery platform Development of internal pipeline with the goal of out-licensing in early stage clinical trials Co-development PharmaIN... is seeking collaborative relationships to capitalize on synergies between our drug delivery platforms and therapeutic molecules with formulation needs. Of particular interest are those... molecules which are currently limited by very short in vivo half-lives, and approved molecules which would have enhanced safety, efficacy, or convenience in our delivery system. Out...

-MRSA PGC GLP-1 PGC Basal Insulin Management Team Elijah M. Bolotin, PhD President, Founder, and Board Member Dr. Bolotin has nearly 20 years in drug delivery, drug development... and management. Prior to PharmaIN, Dr. Bolotin was Group Leader, Drug Delivery, and Technical Leader for New Technology Evaluation at Endorex Corp. (IL), and a research scientist...

focus on combining scientific and business rigor with good humor and a comfortable working environment conducive to high productivity. If you have skills in drug delivery, polymer...

(PGC) in Imaging and Therapy: A Platform for the Delivery of Covalently and Non-Covalently Bound Drugs. Theranostics 2(6): 553-576. Medarova, Z., et al., Noninvasive magnetic... reporter probe in tumor microenvironment. Neoplasia, 2002. 4(3): p. 228-36. Bogdanov, A.A., M. Lewin, and R. Weissleder, Approaches and agents for imaging the vascular system. Adv Drug.... AJR Am J Roentgenol, 1998. 171(1): p. 137-43. Marecos, E., R. Weissleder, and A. Bogdanov, Jr., Antibody-mediated versus nontargeted delivery in a human small cell lung carcinoma...